In Diabetes Patients, IDegLira Combination Drug Superior in Controlling Glucose and Reducing Weight
insulin resistance, News, Type 2 Diabetes News
A clinical trial led by researchers at the UT Southwestern Medical Center revealed that IDegLira, a combination treatment with a new long-acting insulin, and liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, improves ... Read more